Indomethacin serves as a potential inhibitor of protein phosphatases

Cellular Physiology and Biochemistry

Volumn 30, Issue 4, 2012, Pages 1014-1022

  Kanno, Takeshi ^a   Tsuchiya, Ayako ^a   Shimizu, Tadashi ^a   Tanaka, Akito ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Indomethacin; Protein phosphatase 1; Protein phosphatase 2A; Protein tyrosine phosphatase 1B

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; EGTAZIC ACID; INDOMETACIN; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PHOSPHATE BUFFERED SALINE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN TYROSINE PHOSPHATASE 1B;

ANIMAL EXPERIMENT; ARTICLE; BINDING ASSAY; CELL ASSAY; CONTROLLED STUDY; DRUG BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

RATTUS;

EID: 84870313599     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341478     Document Type: Article

References (26)

1. Etminan M, Gill S, Samii A: Effect of nonsteroidal anti-inflammatory drugs on risk of Alzheimers disease: systematic review and meta-analysis of observational studies. Br Med J 2003;327:128.
2. In't Veld BA, Ruitenberg A, Hofman A, Launer LJ, Van Duijn CM, Stijnen T, Breteler MM, Stricker B: Nonsteroidal antiinflammatory drugs and the risk of Alzheimers disease. N Eng J Med 2001;345:1515-1521. (Pubitemid 33144916)
3. Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN: Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimers disease: a systematic review. Neuroepidemiology 2004;23:159-169. (Pubitemid 38980441)
4. Townsend KP, Praticò D: Novel therapeutic opportunities for Alzheimers disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J 2005;19:1592-1601. (Pubitemid 41429517)
5. Kanno T, Yaguchi T, Nagata T, Shimizu T, Tanaka A, Nishizaki T: Indomethacin enhances learning and memory potential by interacting with CaMKII. J Cell Physiol 2011;227:919-926.
6. Kanno T, Yaguchi T, Nagata T, Nishizaki T: Indomethacin activates protein kinase C and potentiates a7 ACh receptor responses. Cell Physiol Biochem 2012;29:189-196.
7. Kanno T, Tsuchiya A, Shimizu T, Tanaka A, Nishizaki T: Novel indomethacin action: selective and direct activation of protein kinase C-s. J Cell Physiol 2012;30:771-777.
8. Kanno T, Yamamoto H, Yaguchi T, Hi R, Mukasa T, Fujikawa H, Nagata T, Yamamoto S, Tanaka A, Nishizaki T: The linoleic acid derivative DCP-LA selectively activates PKC-s, possibly binding to the phosphatidylserine binding site. J Lipid Res 2006;47:1146-1156. (Pubitemid 43830706)
9. Shimizu T, Kanno T, Tanaka A, Nishizaki T: a, f3-DCP-LA selectively activates PKC-s and stimulates neurotransmitter release with the highest potency among 4 diastereomers. Cell Physiol Biochem 2011;27:149-158.
10. Kanno T, Yaguchi T, Nagata T, Tanaka A, Nishizaki T: DCP-LA stimulates AMPA receptor exocytosis through CaMKII activation due to PP-1 inhibition. J Cell Physiol 2009;221:183-188.
11. Baba Y, Hirukawa N, Tanohira N, Sodeoka M: Structure-based design of a highly selective catalytic sitedirected inhibitor of Ser/Thr protein phosphatase 2B (calcineurin). J Am Chem Soc 2003;125;9740-9749. (Pubitemid 36975936)
12. Rice RL, Rusnak JM, Yokokawa F, Yokokawa S, Messner DJ, Boynton AL, Wipf P, Lazo JS: A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation. Biochemistry 1997;36:15965-15974. (Pubitemid 28027401)
13. Endo S, Zhou X, Connor J, Wang B, Shenolikar S: Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor. Biochemistry 1996;35:5220-5228. (Pubitemid 26129461)
14. Huang KX, Paudel HK: Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor. Proc Natl Acad Sci USA 2000;97:5824-5829. (Pubitemid 30367483)
15. 2+ /calmodulin kinase-II in modulating cellular functions. Enzyme Res 2011;2011:587359.
16. Swingle M, Ni L, Honkanen RE: Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse. Methods Mol Biol 2007;365:23-38.
17. Swarup G, Cohen S, Garbers DL: Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun 1982;107:1104-1109. (Pubitemid 13207692)
18. Lisman JE, Zhabotinsky AM: A model of synaptic memory: a CaMKII/PP1 switch that potentiates transmission by organizing an AMPA receptor anchoring assembly. Neuron 2001;31:191-201. (Pubitemid 32762974)
19. Millward TA, Zolnierowicz S, Hemmings BA: Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999;24:186-191. (Pubitemid 29348452)
20. Gao T, Furnari F, Newton AC: PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 2005;18:13-24. (Pubitemid 40444644)
21. Zhang Q, Claret FX: Phosphatases: the new brakes for cancer development? Enzyme Res 2012;2012:659649.
22. Bae D, Ceryak S: Raf-independent, PP2A-dependent MEK activation in response to ERK silencing. Biochem Biophys Res Commun 2009;385:523-527.
23. Byon JC, Kusari AB, Kusari J: Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction. Mol Cell Biochem 1998;182:101-108. (Pubitemid 28181653)
24. Walchli S, Curchod ML, Gobert R P, Arkinstall S, Hooft Van Huijsduijnen R: Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on 'substratetrapping' mutants. J Biol Chem 2000;275:9792-9796. (Pubitemid 30185214)
25. Salmeen A, Andersen JN, Myers MP, Tonks NK, Barford D: Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell 2000;6:1401-1412. (Pubitemid 32045932)
26. Haj FG, Markova B, Klaman LD, Bohmer FD, Neel BG: Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatase-1B. J Biol Chem 2003;278:739-744. (Pubitemid 36790744)